|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.1 NOK | 0.00% |
|
+15.45% | -40.83% |
| 19/04 | EXACT Therapeutics AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Exact Therapeutics Wins Regulatory Approvals for Patient Recruitment in Dose Expansion Study | MT |
EXACT Therapeutics AS announced that its Board Member, Dr. Jean-Claude Provost will step down with immediate effect. Dr. Provost has taken on a new role as interim CMO of Lantheus Holdings. As this could represent a conflict of interest with his current Board appointment to EXACT-Tx, the Company and Dr. Provost have agreed that he will resign from the Board of Directors with immediate effect.
The Nomination Committee is recommending that he is not replaced at the AGM in June.
| 1st Jan change | Capi. | |
|---|---|---|
| -40.83% | 2.1Cr | |
| +23.77% | 4.5TCr | |
| +0.35% | 4.26TCr | |
| +46.00% | 4.18TCr | |
| -5.31% | 2.9TCr | |
| +10.82% | 2.61TCr | |
| -21.16% | 1.9TCr | |
| +6.38% | 1.28TCr | |
| +29.23% | 1.21TCr | |
| -3.33% | 1.18TCr |
EXACT THERAPEUTICS 